Alzheimer's disease: Intraneuronal alterations precede insoluble amyloid-β formation

Neurobiology of Aging

Volumn 25, Issue 6, 2004, Pages 713-718

  Braak, Heiko ^a   Del Tredici, Kelly ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BRAIN NERVE CELL; CLINICAL FEATURE; CYTOSKELETON; INTRACELLULAR SPACE; NERVOUS SYSTEM; NOTE; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; SOLUBILITY; TAUOPATHY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CYTOSKELETON; HUMANS; NEUROFIBRILLARY TANGLES; NEURONS; PEPTIDE FRAGMENTS; TAUOPATHIES;

EID: 2542567240     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.12.015     Document Type: Note

References (55)

1. Adams C. Alzheimer's disease research: a game of connect the dots. Gerontology. 43:1997;8-19
2. Amaral DG, Insausti R. Hippocampal formation. In: Paxinos G, editor. The human nervous system. San Diego: Academic Press; 1990. p. 711-55.
3. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex. 1:1991;103-116
4. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., Wiche G., et al. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477:1989;90-99
5. Bobinski M., Wegiel J., Tarnawski M., de Leon M.J., Reisberg B., Miller D.C., et al. Duration of neurofibrillary changes in the hippocampal pyramidal neurons. Brain Res. 799:1998;156-158
6. Braak E., Braak H., Mandelkow E.M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 87:1994;554-567
7. Braak H., Braak E. Alzheimer's disease: amyloid deposits and neurofibrillary changes in the striatum. J. Neuropathol. Exp. Neurol. 49:1990;215-224
8. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259
9. Braak H, Braak E. Pathology of Alzheimer's disease. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: Saunders; 1994. p. 585-613.
10. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging. 18:1997;351-357
11. Braak H, Braak E. Temporal sequence of Alzheimer's disease-related pathology. In: Peters A, Morrison JH, editors. Neurodegenerative and age-related changes in structure and function of the cerebral cortex. Cerebral cortex, vol. 14. New York: Kluwer Academic/Plenum Publications; 1999. p. 475-512.
12. Braak H, Braak E. Neuropathological stages of Alzheimer's disease. In: de Leon MJ, editor. An atlas of Alzheimer's disease. New York, London: Parthenon Publications; 1999. p. 57-74.
13. Braak H, Braak E, Yilmazer D, Schultz C, Bohl J. Age-related changes of the human cerebral cortex. In: Cruz-Sanchez FF, Ravid R, Cuzner ML, editors. Neuropathologic diagnostic criteria for brain banking. Amsterdam: IOS Press; 1995. p. 14-9.
14. Braak H., Braak E., Yilmazer D., Bohl J. Functional anatomy of human hippocampal formation and related structures. J. Child Neurol. 11:1996;265-275
15. Braak H, Del Tredici K, Schultz C, Braak E. Vulnerability of select neuronal types to Alzheimer's disease. In: Khachaturian ZS, Mesulam MM, editors. Alzheimer's disease. A compendium of current theories. Ann NY Acad Sci 2000;924:53-61.
16. Braak H, Del Tredici K, Braak E. Spectrum of pathology. In: Petersen R, editor. Mild cognitive impairment. New York: Oxford University Press; 2003. p. 149-89.
17. Buée L., Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol. 9:1999;681-693
18. Busch C., Bohl J., Ohm T.G. Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol. Aging. 18:1997;401-406
19. Crain B.J., Burger P.C. The laminar distribution of neuritic plaques in the fascia dentata of patients with Alzheimer's disease. Acta Neuropathol. 76:1988;87-93
20. Dickson D.W. Neurodegenerative diseases with cytoskeletal pathology: a biochemical classification. Ann. Neurol. 42:1997;541-554
21. Dickson D.W. Tau and synuclein and their role in neuropathology. Brain Pathol. 9:1999;657-661
22. Dickson D.W., Crystal H.A., Mattiace L.A., Masur D.M., Blau A.D., Davies P., et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging. 13:1991;179-189
23. German D.C., White C.L., Sparkman D.R. Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience. 21:1987;305-312
24. Goedert M, Trojanowski JQ, Lee VMY. The neurofibrillary pathology of Alzheimer's disease. In: Rosenberg RN, editor. The molecular and genetic basis of neurological disease. 2nd ed. Boston: Butterworth-Heinemann; 1997. p. 613-27.
25. Hardy J.A. An anatomical cascade hypothesis for Alzheimer's disease. Trends Neurosci. 15:1992;200-201
26. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:1992;184-185
27. Hardy J.A., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:2002;353-356
28. Hyman B.T. New neuropathological criteria for Alzheimer's disease. Arch Neurol. 55:1998;1174-1176
29. Hyman B.T., Goméz-Isla T. Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol. Aging. 15:1994;353-354
30. Hyman B.T., Trojanowski J.Q. Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;1095-1097
31. Hyman B.T., van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 225:1984;1168-1170
32. Hyman B.T., van Hoesen G.W., Damasio A.R. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology. 40:1990;1721-1730
33. Kalus P., Braak H., Braak E., Bohl J. The presubicular region in Alzheimer's disease: topography of amyloid deposits and neurofibrillary changes. Brain Res. 494:1989;198-203
34. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:2003;486-489
35. Kemper TL. Senile dementia: a focal disease in the temporal lobe. In: Nandy E, editor. Senile dementia: a biomedical approach. Amsterdam: Elsevier, Amsterdam; 1978. p. 105-13.
36. 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci.: USA. 95:1998;6448-6453
37. Mesulam M.M., Hersh L.B., Mash D.C., Geula C. Differential cholinergic innervation within functional subdivisions of the human cerebral cortex - a choline acetyltransferase study. J. Comp. Neurol. 318:1992;316-328
38. Rosene DL, van Hoesen GW. The hippocampal formation of the primate brain. A review of some comparative aspects of cytoarchitecture and connections. In: Jones EG, Peters A, editors. The cerebral cortex. Further aspects of cortical function, including hippocampus, vol. 6. New York: Plenum Press; 1987. p. 345-456.
39. Saper CB. Diffuse cortical projection systems: anatomical organization and role in cortical function. In: Plum F, editor. The nervous system. Handbook of physiology, vol. 5. Bethesda: American Physiological Society; 1987. p. 169-210.
40. Saper CP. Cholinergic system. In: Paxinos G, editor. The human nervous system. New York: Academic Press; 1990. p. 1095-113.
41. Sassin I., Schultz C., Thal D.R., Rüb U., Arai K., Koppers D., et al. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol. 100:2000;259-269
42. Schonheit B, Zarski R, Ohm TG, Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 2004;25697-711.
43. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498
44. Selkoe D.J. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16:1993;403-409
45. Selkoe D.J. Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53:1994;438-447
46. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science. 298:2002;789-791
47. Selkoe D.J. Deciphering the genesis and fate of amyloid β-protein yields novel therapies for Alzheimer's disease. J. Clin. Invest. 110:2002;1375-1381
48. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., et al. Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161:2002;1869-1879
49. Thal D.R., Rüb U., Schultz C., Sassin I., Ghebremedhin E., Del Tredici K., et al. Sequence of Aβ-protein deposition in the human medial temporal lobe. J. Neuropathol. Exp. Neurol. 59:2000;733-748
50. Tolnay M., Probst A. Review: tau protein pathology in Alzheimer's disease and related disorders. Neuropathol. Appl. Neurobiol. 25:1999;171-187
51. Trojanowski J.Q., Lee V.M.Y. "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann. NY Acad. Sci. 924:2000;62-67
52. van Hoesen G.W., Hyman B.T. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog. Brain Res. 83:1990;445-457
53. Walsh D.M., Klyubin I., Fadeeva J.V., Rowan M.J., Selkoe D.J. Amyloid-β-oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30:2001;552-557
54. Walker L.C., LeVine H. The cerebral proteopathies. Mol. Neurobiol. 21:2000;83-95
55. Zilles K. Architecture of the human cortex. In: Paxinos G, Mai JK, editors. The human nervous system. 2nd ed. San Diego and London: Elsevier Academic Press; 2004. p. 997-1060.